Trial Profile
Effects of aliskiren versus ramipril on arterial stiffness and wave reflection in treatment-naive patients with essential hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jul 2011
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Ramipril (Primary)
- Indications Essential hypertension
- Focus Pharmacodynamics
- 10 Jul 2011 New trial record
- 20 Jun 2011 Results presented at the 21st European Meeting on Hypertension.
- 20 Jun 2011 Results presented at the 21st European Meeting on Hypertension.